XML 25 R10.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value Measurement
3 Months Ended
Mar. 31, 2019
Fair Value Disclosures [Abstract]  
Fair Value Measurement Fair value measurement
For a discussion of the Firm’s valuation methodologies for assets, liabilities and lending-related commitments measured at fair value and the fair value hierarchy, refer to Note 2 of JPMorgan Chase’s 2018 Form 10-K.

The following table presents the assets and liabilities reported at fair value as of March 31, 2019, and December 31, 2018, by major product category and fair value hierarchy.
Assets and liabilities measured at fair value on a recurring basis







Fair value hierarchy

Derivative
netting
adjustments
(f)

 
 
 
 
 
 
 
March 31, 2019 (in millions)
Level 1
Level 2

Level 3

Total fair value

Federal funds sold and securities purchased under resale agreements
$

$
13,969


$


$

$
13,969

Securities borrowed

5,642





5,642

Trading assets:












Debt instruments:












Mortgage-backed securities:












U.S. government agencies(a)

96,098


412



96,510

Residential – nonagency

2,119


85



2,204

Commercial – nonagency

1,873


17



1,890

Total mortgage-backed securities

100,090


514



100,604

U.S. Treasury and government agencies(a)
92,642

10,071





102,713

Obligations of U.S. states and municipalities

6,200


623



6,823

Certificates of deposit, bankers’ acceptances and commercial paper

3,029

 

 

3,029

Non-U.S. government debt securities
39,316

32,546

 
170

 

72,032

Corporate debt securities

21,875

 
568

 

22,443

Loans(b)

42,671

 
1,741

 

44,412

Asset-backed securities

2,495

 
119

 

2,614

Total debt instruments
131,958

218,977

 
3,735

 

354,670

Equity securities
107,042

337

 
202

 

107,581

Physical commodities(c)
4,665

2,480

 

 

7,145

Other

13,323

 
304

 

13,627

Total debt and equity instruments(d)
243,665

235,117

 
4,241

 

483,023

Derivative receivables:
 
 
 
 
 
 
 
Interest rate
1,799

289,034

 
1,434

 
(269,509
)
22,758

Credit

15,140

 
780

 
(15,196
)
724

Foreign exchange
595

148,848

 
552

 
(138,124
)
11,871

Equity

40,286

 
2,978

 
(33,942
)
9,322

Commodity

14,839

 
190

 
(9,371
)
5,658

Total derivative receivables
2,394

508,147

 
5,934

 
(466,142
)
50,333

Total trading assets(e)
246,059

743,264

 
10,175

 
(466,142
)
533,356

Available-for-sale securities:
 
 
 
 
 
 
 
Mortgage-backed securities:
 
 
 
 
 
 
 
U.S. government agencies(a)

74,923

 

 

74,923

Residential – nonagency

10,113

 

 

10,113

Commercial – nonagency

6,687

 

 

6,687

Total mortgage-backed securities

91,723

 

 

91,723

U.S. Treasury and government agencies
58,764


 

 

58,764

Obligations of U.S. states and municipalities

34,487

 

 

34,487

Certificates of deposit

75

 

 

75

Non-U.S. government debt securities
14,321

7,714

 

 

22,035

Corporate debt securities

1,792

 

 

1,792

Asset-backed securities:
 
 
 
 
 
 
 
Collateralized loan obligations

20,929

 

 

20,929

Other

6,711

 

 

6,711

Total available-for-sale securities
73,085

163,431

 

 

236,516

Loans

3,596

 
123

 

3,719

Mortgage servicing rights


 
5,957

 

5,957

Other assets(e)
8,663

83

 
841

 

9,587

Total assets measured at fair value on a recurring basis
$
327,807

$
929,985

 
$
17,096

 
$
(466,142
)
$
808,746

Deposits
$

$
27,276

 
$
4,528

 
$

$
31,804

Federal funds purchased and securities loaned or sold under repurchase agreements

971

 

 

971

Short-term borrowings

5,696

 
1,502

 

7,198

Trading liabilities:
 
 
 
 
 
 


Debt and equity instruments(d)
95,128

22,724

 
52

 

117,904

Derivative payables:
 
 
 
 
 
 


Interest rate
2,507

258,282

 
1,581

 
(254,648
)
7,722

Credit

16,144

 
895

 
(15,056
)
1,983

Foreign exchange
550

146,574

 
908

 
(136,634
)
11,398

Equity

40,601

 
5,044

 
(34,616
)
11,029

Commodity

16,278

 
855

 
(10,262
)
6,871

Total derivative payables
3,057

477,879

 
9,283

 
(451,216
)
39,003

Total trading liabilities
98,185

500,603

 
9,335

 
(451,216
)
156,907

Accounts payable and other liabilities
3,186

76

 
15

 

3,277

Beneficial interests issued by consolidated VIEs

13

 

 

13

Long-term debt

39,586

 
21,655

 

61,241

Total liabilities measured at fair value on a recurring basis
$
101,371

$
574,221

 
$
37,035

 
$
(451,216
)
$
261,411



Fair value hierarchy

Derivative
netting
adjustments
(f)
 

 
 
 
 
 
 
 
 
December 31, 2018 (in millions)
Level 1
Level 2

Level 3

 
Total fair value

Federal funds sold and securities purchased under resale agreements
$

$
13,235


$


$

 
$
13,235

Securities borrowed

5,105





 
5,105

Trading assets:
 
 

 

 
 
 
Debt instruments:
 
 

 

 
 
 
Mortgage-backed securities:
 
 

 

 
 
 
U.S. government agencies(a)

76,249


549



 
76,798

Residential – nonagency

1,798


64



 
1,862

Commercial – nonagency

1,501


11



 
1,512

Total mortgage-backed securities

79,548


624



 
80,172

U.S. Treasury and government agencies(a)
51,477

7,702





 
59,179

Obligations of U.S. states and municipalities

7,121


689



 
7,810

Certificates of deposit, bankers’ acceptances and commercial paper

1,214





 
1,214

Non-U.S. government debt securities
27,878

27,056


155



 
55,089

Corporate debt securities

18,655


334



 
18,989

Loans(b)

40,047


1,706



 
41,753

Asset-backed securities

2,756


127



 
2,883

Total debt instruments
79,355

184,099


3,635



 
267,089

Equity securities
71,119

482


232



 
71,833

Physical commodities(c)
5,182

1,855





 
7,037

Other

13,192


301



 
13,493

Total debt and equity instruments(d)
155,656

199,628


4,168



 
359,452

Derivative receivables:
 








 


Interest rate
682

266,380


1,642


(245,490
)
 
23,214

Credit

19,235


860


(19,483
)
 
612

Foreign exchange
771

166,238


676


(154,235
)
 
13,450

Equity

46,777


2,508


(39,339
)
 
9,946

Commodity

20,339


131


(13,479
)
 
6,991

Total derivative receivables
1,453

518,969


5,817


(472,026
)
 
54,213

Total trading assets(e)
157,109

718,597


9,985


(472,026
)
 
413,665

Available-for-sale securities:
 








 


Mortgage-backed securities:
 








 


U.S. government agencies(a)

68,646





 
68,646

Residential – nonagency

8,519


1



 
8,520

Commercial – nonagency

6,654





 
6,654

Total mortgage-backed securities

83,819


1



 
83,820

U.S. Treasury and government agencies
56,059






 
56,059

Obligations of U.S. states and municipalities

37,723





 
37,723

Certificates of deposit

75





 
75

Non-U.S. government debt securities
15,313

8,789





 
24,102

Corporate debt securities

1,918





 
1,918

Asset-backed securities:
 








 


Collateralized loan obligations

19,437





 
19,437

Other

7,260





 
7,260

Total available-for-sale securities
71,372

159,021


1



 
230,394

Loans

3,029


122



 
3,151

Mortgage servicing rights



6,130



 
6,130

Other assets(e)
7,810

195


927



 
8,932

Total assets measured at fair value on a recurring basis
$
236,291

$
899,182


$
17,165


$
(472,026
)
 
$
680,612

Deposits
$

$
19,048


$
4,169


$

 
$
23,217

Federal funds purchased and securities loaned or sold under repurchase agreements

935





 
935

Short-term borrowings

5,607


1,523



 
7,130

Trading liabilities:
 
 

 



 


Debt and equity instruments(d)
80,199

22,755


50



 
103,004

Derivative payables:
 
 




 
 
 
Interest rate
1,526

239,576


1,680


(234,998
)
 
7,784

Credit

19,309


967


(18,609
)
 
1,667

Foreign exchange
695

163,549


973


(152,432
)
 
12,785

Equity

46,462


4,733


(41,034
)
 
10,161

Commodity

21,158


1,260


(13,046
)
 
9,372

Total derivative payables
2,221

490,054


9,613


(460,119
)
 
41,769

Total trading liabilities
82,420

512,809


9,663


(460,119
)
 
144,773

Accounts payable and other liabilities
3,063

196


10



 
3,269

Beneficial interests issued by consolidated VIEs

27


1



 
28

Long-term debt

35,468


19,418



 
54,886

Total liabilities measured at fair value on a recurring basis
$
85,483

$
574,090


$
34,784


$
(460,119
)
 
$
234,238

(a)
At March 31, 2019, and December 31, 2018, included total U.S. government-sponsored enterprise obligations of $128.0 billion and $92.3 billion, respectively, which were predominantly mortgage-related.
(b)
At March 31, 2019, and December 31, 2018, included within trading loans were $15.2 billion and $13.2 billion, respectively, of residential first-lien mortgages, and $2.7 billion and $2.3 billion, respectively, of commercial first-lien mortgages. Residential mortgage loans include conforming mortgage loans originated with the intent to sell to U.S. government agencies of $8.1 billion and $7.6 billion, respectively.
(c)
Physical commodities inventories are generally accounted for at the lower of cost or net realizable value. “Net realizable value” is a term defined in U.S. GAAP as not exceeding fair value less costs to sell (“transaction costs”). Transaction costs for the Firm’s physical commodities inventories are either not applicable or immaterial to the value of the inventory. Therefore, net realizable value approximates fair value for the Firm’s physical commodities
inventories. When fair value hedging has been applied (or when net realizable value is below cost), the carrying value of physical commodities approximates fair value, because under fair value hedge accounting, the cost basis is adjusted for changes in fair value. For a further discussion of the Firm’s hedge accounting relationships, refer to Note 4. To provide consistent fair value disclosure information, all physical commodities inventories have been included in each period presented.
(d)
Balances reflect the reduction of securities owned (long positions) by the amount of identical securities sold but not yet purchased (short positions).
(e)
Certain investments that are measured at fair value using the net asset value per share (or its equivalent) as a practical expedient are not required to be classified in the fair value hierarchy. At March 31, 2019, and December 31, 2018, the fair values of these investments, which include certain hedge funds, private equity funds, real estate and other funds, were $736 million and $747 million, respectively. Included in these balances at March 31, 2019, and December 31, 2018, were trading assets of $46 million and $49 million, respectively, and other assets of $690 million and $698 million, respectively.
(f)
As permitted under U.S. GAAP, the Firm has elected to net derivative receivables and derivative payables and the related cash collateral received and paid when a legally enforceable master netting agreement exists. The level 3 balances would be reduced if netting were applied, including the netting benefit associated with cash collateral.Level 3 valuations
For further information on the Firm’s valuation process and a detailed discussion of the determination of fair value for individual financial instruments, refer to Note 2 of JPMorgan Chase’s 2018 Form 10-K.
The following table presents the Firm’s primary level 3 financial instruments, the valuation techniques used to measure the fair value of those financial instruments, the significant unobservable inputs, the range of values for those inputs and, for certain instruments, the weighted averages of such inputs. While the determination to classify an instrument within level 3 is based on the significance of the unobservable inputs to the overall fair value measurement, level 3 financial instruments typically include observable components (that is, components that are actively quoted and can be validated to external sources) in addition to the unobservable components. The level 1 and/or level 2 inputs are not included in the table. In addition, the Firm manages the risk of the observable components of level 3 financial instruments using securities and derivative positions that are classified within levels 1 or 2 of the fair value hierarchy.
The range of values presented in the table is representative of the highest and lowest level input used to value the significant groups of instruments within a product/instrument classification. Where provided, the weighted averages of the input values presented in the table are calculated based on the fair value of the instruments that the input is being used to value.
In the Firm’s view, the input range and the weighted average value do not reflect the degree of input uncertainty or an assessment of the reasonableness of the Firm’s estimates and assumptions. Rather, they reflect the characteristics of the various instruments held by the Firm and the relative distribution of instruments within the range of characteristics. For example, two option contracts may have
similar levels of market risk exposure and valuation uncertainty, but may have significantly different implied volatility levels because the option contracts have different underlyings, tenors, or strike prices. The input range and weighted average values will therefore vary from period-to-period and parameter-to-parameter based on the characteristics of the instruments held by the Firm at each balance sheet date.
For the Firm’s derivatives and structured notes positions classified within level 3 at March 31, 2019, interest rate correlation inputs used in estimating fair value were concentrated towards the upper end of the range; equity correlation, equity-FX, and equity-IR correlation inputs were concentrated in the middle of the range; commodity correlation inputs were concentrated in the middle of the range; credit correlation inputs were concentrated towards the lower end of the range; and the interest rate-foreign exchange (“IR-FX”) correlation inputs were distributed across the range. In addition, the interest rate spread volatility inputs used in estimating fair value were distributed across the range; equity volatilities and commodity volatilities were concentrated towards the lower end of the range; and forward commodity prices used in estimating the fair value of commodity derivatives were concentrated in the middle of the range. Prepayment speed inputs used in estimating fair value of interest rate derivatives were concentrated towards the lower end of the range. Recovery rate inputs used in estimating fair value of credit derivatives were distributed across the range; credit spreads and conditional default rates were concentrated towards the lower end of the range; loss severity inputs were concentrated towards the upper end of the range and price inputs were concentrated towards the lower end of the range.

Level 3 inputs(a)
 
 
 
 
 
 
March 31, 2019
 
 
 
 
 
 
Product/Instrument
Fair value
(in millions)
 
Principal valuation technique
Unobservable inputs(g)
Range of input values
Weighted average
 
Residential mortgage-backed securities and loans(b)
$
748

 
Discounted cash flows
Yield
0
 %
18
%
 
7
%
 
 
 
Prepayment speed
0
 %
22
%
 
11
%
 
 
 
 
Conditional default rate
0
 %
5
%
 
1
%
 
 
 
 
Loss severity
0
 %
100
%
 
3
%
Commercial mortgage-backed securities and loans(c)
397

 
Market comparables
Price
$
0

$
102

 
$
87

Obligations of U.S. states and municipalities
623

 
Market comparables
Price
$
63

$
100

 
$
98

Corporate debt securities
568

 
Market comparables
Price
$
0

$
111

 
$
82

Loans(d)
226

 
Discounted cash flows
Yield
6
 %
18
%
 
8
%
 
1,007

 
Market comparables
Price
$
2

$
102

 
$
80

Asset-backed securities
119

 
Market comparables
Price
$
0

$
105

 
$
65

Net interest rate derivatives
(217
)
 
Option pricing
Interest rate spread volatility
16
 bps
38
 bps
 
 
 
 
 
Interest rate correlation
(25
)%
97
%
 
 
 
 
 
 
IR-FX correlation
45
 %
60
%
 
 
 
70

 
Discounted cash flows
Prepayment speed
4
 %
30
%
 
 
Net credit derivatives
(162
)
 
Discounted cash flows
Credit correlation
30
 %
55
%
 
 
 
 
 
 
Credit spread
6
 bps
1,396
 bps
 
 
 
 
 
 
Recovery rate
20
 %
70
%
 
 
 
 
 
 
Conditional default rate
1
 %
93
%
 
 
 
 
 
 
Loss severity
100%
 
 
 
47

 
Market comparables
Price
$
1

$
115

 
 
Net foreign exchange derivatives
(198
)
 
Option pricing
IR-FX correlation
(50
)%
60
%
 
 
 
(158
)
 
Discounted cash flows
Prepayment speed
9%
 
 
Net equity derivatives
(2,066
)
 
Option pricing
Equity volatility
14
 %
65
%
 
 
 
 
 
 
Equity correlation
25
 %
98
%
 
 
 
 
 
 
Equity-FX correlation
(75
)%
59
%
 
 
 
 
 
 
Equity-IR correlation
20
 %
60
%
 
 
Net commodity derivatives
(665
)
 
Option pricing
Forward commodity price
$
52

$ 69 per barrel
 
 
 
 
Commodity volatility
5
 %
57
%
 
 
 
 
 
 
Commodity correlation
(51
)%
95
%
 
 
MSRs
5,957

 
Discounted cash flows
Refer to Note 14
 
 
Other assets
214

 
Discounted cash flows
Credit spread
55bps
 
 
55bps

 
 
 
 
Yield
8
 %
10
%
 
9
%
 
930

 
Market comparables
Price
$
19

$
110

 
$
34

Long-term debt, short-term borrowings, and deposits(e)
27,685

 
Option pricing
Interest rate spread volatility
16
 bps
38
 bps
 
 
 
 
Interest rate correlation
(25
)%
97
%
 
 
 
 
 
IR-FX correlation
(50
)%
60
%
 
 
 
 
 
Equity correlation
25
 %
98
%
 
 
 
 
 
Equity-FX correlation
(75
)%
59
%
 
 
 
 
 
Equity-IR correlation
20
 %
60
%
 
 
Other level 3 assets and liabilities, net(f)
305

 
 
 
 
 
 
 
 
(a)
The categories presented in the table have been aggregated based upon the product type, which may differ from their classification on the Consolidated balance sheets. Furthermore, the inputs presented for each valuation technique in the table are, in some cases, not applicable to every instrument valued using the technique as the characteristics of the instruments can differ.
(b)
Includes U.S. government agency securities of $408 million, nonagency securities of $85 million and trading loans of $255 million.
(c)
Includes U.S. government agency securities of $4 million, nonagency securities of $17 million, trading loans of $253 million and non-trading loans of $123 million.
(d)
Comprises trading loans.
(e)
Long-term debt, short-term borrowings and deposits include structured notes issued by the Firm that are financial instruments that typically contain embedded derivatives. The estimation of the fair value of structured notes includes the derivative features embedded within the instrument. The significant unobservable inputs are broadly consistent with those presented for derivative receivables.
(f)
Includes level 3 assets and liabilities that are insignificant both individually and in aggregate.
(g)
Price is a significant unobservable input for certain instruments. When quoted market prices are not readily available, reliance is generally placed on price-based internal valuation techniques. The price input is expressed assuming a par value of $100.
Changes in and ranges of unobservable inputs
For a discussion of the impact on fair value of changes in unobservable inputs and the relationships between unobservable inputs as well as a description of attributes of the underlying instruments and external market factors that affect the range of inputs used in the valuation of the Firm’s positions refer to Note 2 of JPMorgan Chase’s 2018 Form 10-K.
Changes in level 3 recurring fair value measurements
The following tables include a rollforward of the Consolidated balance sheets amounts (including changes in fair value) for financial instruments classified by the Firm within level 3 of the fair value hierarchy for the three months ended March 31, 2019 and 2018. When a determination is made to classify a financial instrument within level 3, the determination is based on the significance of the unobservable inputs to the overall fair
value measurement. However, level 3 financial instruments typically include, in addition to the unobservable or level 3 components, observable components (that is, components that are actively quoted and can be validated to external sources); accordingly, the gains and losses in the table below include changes in fair value due in part to observable factors that are part of the valuation methodology. Also, the Firm risk-manages the observable components of level 3 financial instruments using securities and derivative positions that are classified within level 1 or 2 of the fair value hierarchy; as these level 1 and level 2 risk management instruments are not included below, the gains or losses in the following tables do not reflect the effect of the Firm’s risk management activities related to such level 3 instruments.


 
Fair value measurements using significant unobservable inputs
 
 
Three months ended
March 31, 2019
(in millions)
Fair value at
January 1,
2019
Total realized/unrealized gains/(losses)
 
 
 
 
Transfers into
level 3
(h)
Transfers (out of) level 3(h)
Fair value at
March 31, 2019
Change in unrealized gains/(losses) related
to financial instruments held at March 31, 2019
Purchases(f)
Sales
 
Settlements(g)
Assets:(a)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Trading assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Debt instruments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mortgage-backed securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. government agencies
$
549

 
$
(15
)
 
$
5

$
(100
)
 
$
(18
)
$
1

$
(10
)
 
$
412

 
$
(16
)
 
Residential – nonagency
64

 
24

 
70

(69
)
 
(1
)
15

(18
)
 
85

 
1

 
Commercial – nonagency
11

 
2

 
12

(19
)
 
(2
)
15

(2
)
 
17

 
1

 
Total mortgage-backed securities
624

 
11

 
87

(188
)
 
(21
)
31

(30
)
 
514

 
(14
)
 
U.S. Treasury and government agencies

 

 


 



 

 

 
Obligations of U.S. states and municipalities
689

 
13

 
1

(74
)
 
(6
)


 
623

 
14

 
Non-U.S. government debt securities
155

 
(1
)
 
71

(54
)
 

2

(3
)
 
170

 
(1
)
 
Corporate debt securities
334

 
22

 
223

(7
)
 

28

(32
)
 
568

 
39

 
Loans
1,706

 
83

 
72

(118
)
 
(120
)
159

(41
)
 
1,741

 
83

 
Asset-backed securities
127

 
(2
)
 
17

(21
)
 
(7
)
20

(15
)
 
119

 
(4
)
 
Total debt instruments
3,635

 
126

 
471

(462
)
 
(154
)
240

(121
)
 
3,735

 
117

 
Equity securities
232

 
(2
)
 
15

(79
)
 
(22
)
75

(17
)
 
202

 
(2
)
 
Other
301

 
4

 
12

(1
)
 
(11
)
1

(2
)
 
304

 
13

 
Total trading assets – debt and equity instruments
4,168

 
128

(c) 
498

(542
)
 
(187
)
316

(140
)
 
4,241

 
128

(c) 
Net derivative receivables:(b)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate
(38
)
 
(322
)
 
19

(147
)
 
298

18

25

 
(147
)
 
(376
)
 
Credit
(107
)
 
(17
)
 

(1
)
 
6

3

1

 
(115
)
 
(21
)
 
Foreign exchange
(297
)
 
(245
)
 
1

(9
)
 
181

(8
)
21

 
(356
)
 
(220
)
 
Equity
(2,225
)
 
731

 
127

(297
)
 
(401
)
(67
)
66

 
(2,066
)
 
226

 
Commodity
(1,129
)
 
533

 
3

(88
)
 
24

1

(9
)
 
(665
)
 
507

 
Total net derivative receivables
(3,796
)
 
680

(c) 
150

(542
)
 
108

(53
)
104

 
(3,349
)
 
116

(c) 
Available-for-sale securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mortgage-backed securities
1

 

 


 
(1
)


 

 

 
Asset-backed securities

 

 


 



 

 

 
Total available-for-sale securities
1

 




 
(1
)


 

 


Loans
122

 
3

(c) 


 
(2
)


 
123

 
3

(c) 
Mortgage servicing rights
6,130

 
(299
)
(e) 
436

(111
)
 
(199
)


 
5,957

 
(299
)
(e) 
Other assets
927

 
(7
)
(c) 
9

(80
)
 
(1
)

(7
)
 
841

 
(10
)
(c) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fair value measurements using significant unobservable inputs
 
 
Three months ended
March 31, 2019
(in millions)
Fair value at
January 1, 2019
Total realized/unrealized (gains)/losses
 
 
 
 
Transfers into
level 3
(h)
Transfers (out of) level 3(h)
Fair value at
March 31, 2019
Change in unrealized (gains)/
losses related
to financial instruments held at March 31, 2019
Purchases
Sales
Issuances
Settlements(g)
Liabilities:(a)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Deposits
$
4,169

 
$
152

(c)(i) 
$

$

$
335

$
(24
)
$

$
(104
)
 
$
4,528

 
$
144

(c)(i) 
Short-term borrowings
1,523

 
46

(c)(i) 


651

(601
)
1

(118
)
 
1,502

 
80

(c)(i) 
Trading liabilities – debt and equity instruments
50

 


(2
)
11



3

(10
)
 
52

 
1

(c) 
Accounts payable and other liabilities
10

 

 
(5
)
10





 
15

 

 
Beneficial interests issued by consolidated VIEs
1

 
(1
)
(c) 






 

 


Long-term debt
19,418

 
1,273

(c)(i) 


2,051

(1,188
)
273

(172
)
 
21,655

 
1,625

(c)(i) 

Fair value measurements using significant unobservable inputs


 
Three months ended
March 31, 2018
(in millions)
Fair value at
January 1,
2018
Total realized/unrealized gains/(losses)



 

Transfers into
level 3(h)
Transfers (out of) level 3(h)
Fair value at
March 31, 2018
Change in unrealized gains/(losses) related
to financial instruments held at March 31, 2018
Purchases(f)
Sales

 
Settlements(g)
Assets:(a)






 


 









Trading assets:






 


 









Debt instruments:






 


 









Mortgage-backed securities:






 


 









U.S. government agencies
$
307

$
3


$
329

$
(87
)

 
$
(20
)
$
4

$
(28
)

$
508


$
1


Residential – nonagency
60

(2
)


(2
)

 
(2
)
29

(28
)

55




Commercial – nonagency
11

1


6

(7
)

 
(1
)
4



14




Total mortgage-backed securities
378

2


335

(96
)

 
(23
)
37

(56
)

577


1


U.S. Treasury and
government agencies
1


 


 
 


(1
)
 

 

 
Obligations of U.S. states and municipalities
744

(2
)

39



 
(77
)



704


(2
)

Non-U.S. government debt securities
78

2


225

(92
)

 

17

(33
)

197


3


Corporate debt securities
312

(1
)

81

(100
)

 
(1
)
131

(116
)

306


(1
)

Loans
2,719

62


470

(728
)

 
(137
)
123

(141
)

2,368


30


Asset-backed securities
153

5


14

(13
)

 
(34
)
11

(73
)

63




Total debt instruments
4,385

68


1,164

(1,029
)

 
(272
)
319

(420
)

4,215


31


Equity securities
295

(8
)

28

(10
)

 

4

(9
)

300


(7
)

Other
690

15


18

(6
)

 
(20
)
1



698


15


Total trading assets – debt and equity instruments
5,370

75

(c) 
1,210

(1,045
)

 
(292
)
324

(429
)

5,213


39

(c) 
Net derivative receivables:(b)










 


 









Interest rate
264

53


17

(4
)

 
46

26

70


472


131


Credit
(35
)
17


1

(2
)

 
4

3

17


5


11


Foreign exchange
(396
)
146



(5
)

 
11

(38
)
(6
)

(288
)

156


Equity
(3,409
)
639


218

(242
)

 
434

(111
)
(41
)

(2,512
)

448


Commodity
(674
)
185





 
12

1

(43
)

(519
)

227


Total net derivative receivables
(4,250
)
1,040

(c) 
236

(253
)

 
507

(119
)
(3
)

(2,842
)

973

(c) 
Available-for-sale securities:
 
 

 
 

 
 
 
 

 

 

Mortgage-backed securities
1






 




1




Asset-backed securities
276

1





 
(73
)



204


1


Total available-for-sale securities
277

1

(d) 



 
(73
)



205


1

(d) 
Loans
276

5

(c) 
122



 
(7
)



396


5

(c) 
Mortgage servicing rights
6,030

384

(e) 
243

(295
)

 
(160
)



6,202


384

(e) 
Other assets
1,265

(37
)
(c) 
23

(14
)
 
 
(16
)

(1
)
 
1,220

 
(38
)
(c) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Fair value measurements using significant unobservable inputs


Three months ended
March 31, 2018
(in millions)
Fair value at
January 1,
2018
Total realized/unrealized (gains)/losses



 

Transfers into
level 3(h)
Transfers (out of) level 3(h)
Fair value at
March 31, 2018
Change in unrealized (gains)/losses related
to financial instruments held at March 31, 2018
Purchases
Sales
Issuances
Settlements(g)
Liabilities:(a)






 


 








Deposits
$
4,142

$
(90
)
(c)(i) 
$

$

$
321

 
$
(198
)
$

$
(158
)

$
4,017


$
(125
)
(c)(i) 
Short-term borrowings
1,665

15

(c)(i) 


1,208

 
(746
)
12

(29
)

2,125


43

(c)(i) 
Trading liabilities – debt and equity instruments
39

3

(c) 
(37
)
43


 
1

2

(1
)

50


5

(c) 
Accounts payable and other liabilities
13



(6
)


 




7




Beneficial interests issued by consolidated VIEs
39






 
(38
)



1




Long-term debt
16,125

(246
)
(c)(i) 


3,091

 
(2,263
)
375

(132
)

16,950


(354
)
(c)(i) 


(a)
Level 3 assets as a percentage of total Firm assets accounted for at fair value (including assets measured at fair value on a nonrecurring basis) were 2% and 3% at March 31, 2019 and December 31, 2018, respectively. Level 3 liabilities as a percentage of total Firm liabilities accounted for at fair value (including liabilities measured at fair value on a nonrecurring basis) were 14% and 15% at March 31, 2019 and December 31, 2018, respectively.
(b)
All level 3 derivatives are presented on a net basis, irrespective of the underlying counterparty.
(c)
Predominantly reported in principal transactions revenue, except for changes in fair value for CCB mortgage loans and lending-related commitments originated with the intent to sell, and mortgage loan purchase commitments, which are reported in mortgage fees and related income.
(d)
Realized gains/(losses) on AFS securities, as well as other-than-temporary impairment (“OTTI”) losses that are recorded in earnings, are reported in investment securities gains/(losses). Unrealized gains/(losses) are reported in OCI. There were no realized gains/(losses) or foreign exchange hedge accounting adjustments recorded in income on AFS securities for the three months ended March 31, 2019 and 2018, respectively. Unrealized gains/(losses) recorded on AFS securities in OCI were zero and $1 million for the three months ended March 31, 2019 and 2018, respectively.
(e)
Changes in fair value for MSRs are reported in mortgage fees and related income.
(f)
Loan originations are included in purchases.
(g)
Includes financial assets and liabilities that have matured, been partially or fully repaid, impacts of modifications, deconsolidations associated with beneficial interests in VIEs and other items.
(h)
All transfers into and/or out of level 3 are based on changes in the observability and/or significance of the valuation inputs and are assumed to occur at the beginning of the quarterly reporting period in which they occur.
(i)
Realized (gains)/losses due to DVA for fair value option elected liabilities are reported in principal transactions revenue, and they were not material for the three months ended March 31, 2019 and 2018, respectively. Unrealized (gains)/losses are reported in OCI, and they were $176 million and $52 million for the three months ended March 31, 2019 and 2018, respectively.
Level 3 analysis
Consolidated balance sheets changes
Level 3 assets, including assets measured at fair value on a nonrecurring basis, were 0.6% of total Firm assets at March 31, 2019. The following describes significant changes to level 3 assets since December 31, 2018, for those items measured at fair value on a recurring basis. For further information on changes impacting items measured at fair value on a nonrecurring basis, refer to Assets and liabilities measured at fair value on a nonrecurring basis on page 83.
Three months ended March 31, 2019
Level 3 assets were $17.1 billion at March 31, 2019, reflecting a decrease of $69 million from December 31, 2018 with no movements that were individually significant.
Transfers between levels for instruments carried at fair value on a recurring basis
For both the three months ended March 31, 2019 and 2018 there were no individually significant transfers.
All transfers are based on changes in the observability and/or significance of the valuation inputs and are assumed to occur at the beginning of the quarterly reporting period in which they occur.
Gains and losses
The following describes significant components of total realized/unrealized gains/(losses) for instruments measured at fair value on a recurring basis for the periods indicated. For further information on these instruments, refer to Changes in level 3 recurring fair value measurements rollforward tables on pages 79–82.
Three months ended March 31, 2019
$505 million of net gains on assets, none of which were individually significant and $1.5 billion of net losses on liabilities predominantly driven by market movements in long-term debt.
Three months ended March 31, 2018
$1.5 billion of net gains on assets and $318 million of net gains on liabilities, none of which were individually significant.Credit and funding adjustments — derivatives
The following table provides the impact of credit and funding adjustments on principal transactions revenue in the respective periods, excluding the effect of any associated hedging activities. The FVA presented below includes the impact of the Firm’s own credit quality on the inception value of liabilities as well as the impact of changes in the Firm’s own credit quality over time.
 
Three months ended March 31,
(in millions)
2019

 
2018

Credit and funding adjustments:
 
 
 
Derivatives CVA
$
60

 
$
84

Derivatives FVA
152

 
(83
)

For further information about both credit and funding adjustments, as well as information about valuation adjustments on fair value option elected liabilities, refer to Note 2 of JPMorgan Chase’s 2018 Form 10-K.Assets and liabilities measured at fair value on a nonrecurring basis
The following tables present the assets held as of March 31, 2019 and 2018, respectively, for which a nonrecurring fair value adjustment was recorded during the three months ended March 31, 2019 and 2018, respectively, by major product category and fair value hierarchy.
 
Fair value hierarchy
 
Total fair value
March 31, 2019 (in millions)
Level 1

Level 2

 
Level 3

 
Loans
$

$
441

 
$
84

(b) 
$
525

Other assets(a)

11

 
456

 
467

Total assets measured at fair value on a nonrecurring basis
$

$
452

 
$
540

 
$
992

 
Fair value hierarchy
 
Total fair value
March 31, 2018 (in millions)
Level 1

Level 2

 
Level 3

 
Loans
$

$
690

 
$
165

 
$
855

Other assets

236

 
572

 
808

Total assets measured at fair value on a nonrecurring basis
$

$
926

 
$
737

 
$
1,663

(a)
Primarily includes equity securities without readily determinable fair values that were adjusted based on observable price changes in orderly transactions from an identical or similar investment of the same issuer (measurement alternative). Of the $456 million in level 3 assets measured at fair value on a nonrecurring basis as of March 31, 2019, $351 million related to such equity securities. These equity securities are classified as level 3 due to the infrequency of the observable prices and/or the restrictions on the shares.
(b)
Of the $84 million in level 3 assets measured at fair value on a nonrecurring basis as of March 31, 2019, $65 million related to residential real estate loans carried at the net realizable value of the underlying collateral (e.g., collateral-dependent loans and other loans charged off in accordance with regulatory guidance). These amounts are classified as level 3 as they are valued using information from broker’s price opinions, appraisals and automated valuation models and discounted based upon the Firm’s experience with actual liquidation values. These discounts ranged from 14% to 49% with a weighted average of 28%.
There were no material liabilities measured at fair value on a nonrecurring basis at March 31, 2019 and at March 31, 2018.
Nonrecurring fair value changes
The following table presents the total change in value of assets and liabilities for which a fair value adjustment has been recognized for the three months ended March 31, 2019 and 2018, related to financial instruments held at those dates.
 
Three months ended March 31,
(in millions)
2019

 
2018

Loans
$
(21
)
 
$
(15
)
Other assets(a)
71

  
496

Total nonrecurring fair value gains/(losses)
$
50

 
$
481

(a)
Included $78 million and $505 million for the three months ended March 31, 2019 and 2018 respectively, of net gains as a result of the measurement alternative.
For further information about the measurement of impaired collateral-dependent loans, and other loans where the carrying value is based on the fair value of the underlying collateral (e.g., residential mortgage loans charged off in accordance with regulatory guidance), refer to Note 12 of JPMorgan Chase’s 2018 Form 10-K.Equity securities without readily determinable fair values
The Firm measures equity securities without readily determinable fair values at cost less impairment (if any), plus or minus observable price changes from an identical or similar investment of the same issuer, with such changes recognized in earnings.
In its determination of the new carrying values upon observable price changes, the Firm may adjust the prices if deemed necessary to arrive at the Firm’s estimated fair values. Such adjustments may include adjustments to reflect the different rights and obligations of similar securities, and other adjustments that are consistent with the Firm’s valuation techniques for private equity direct investments.
The following table presents the carrying value of equity securities without readily determinable fair values still held as of March 31, 2019 and March 31, 2018, that are measured under the measurement alternative and the related adjustments recorded during the periods presented for those securities with observable price changes. These securities are included in the nonrecurring fair value tables when applicable price changes are observable.
 
Three months ended
 
March 31,
As of or for the period ended,
 
 
 
(in millions)
2019
 
2018
Other assets
 
 
 
Carrying value(a)
$
1,819

 
$
1,429

Upward carrying value changes(b)
84

 
505

Downward carrying value changes/impairment(c)
(6
)
 

(a)
The carrying value as of December 31, 2018 was $1.5 billion.
(b)
The cumulative upward carrying value changes between January 1, 2018 and March 31, 2019 were $393 million.
(c)
The cumulative downward carrying value changes/impairment between January 1, 2018 and March 31, 2019 were $(166) million.
Included in other assets above is the Firm’s interest in approximately 40 million Visa Class B shares, recorded at a nominal carrying value. These shares are subject to certain transfer restrictions currently and will be convertible into Visa Class A shares upon final resolution of certain litigation matters involving Visa. The conversion rate of Visa Class B shares into Visa Class A shares is 1.6298 at March 31, 2019, and may be adjusted by Visa depending on developments related to the litigation matters.Additional disclosures about the fair value of financial instruments that are not carried on the Consolidated balance sheets at fair value
The following table presents by fair value hierarchy classification the carrying values and estimated fair values at March 31, 2019, and December 31, 2018, of financial assets and liabilities, excluding financial instruments that are carried at fair value on a recurring basis, and their classification within the fair value hierarchy.
 
March 31, 2019
 
December 31, 2018
 
 
Estimated fair value hierarchy
 
 
 
Estimated fair value hierarchy
 
(in billions)
Carrying
value
Level 1
Level 2
Level 3
Total estimated
fair value
 
Carrying
value
Level 1
Level 2
Level 3
Total estimated
fair value
Financial assets
 
 
 
 
 
 
 
 
 
 
 
Cash and due from banks
$
21.9

$
21.9

$

$

$
21.9

 
$
22.3

$
22.3

$

$

$
22.3

Deposits with banks
280.7

280.7



280.7

 
256.5

256.5



256.5

Accrued interest and accounts receivable
71.2


71.1

0.1

71.2

 
72.0


71.9

0.1

72.0

Federal funds sold and securities purchased under resale agreements
285.2


285.2


285.2

 
308.4


308.4


308.4

Securities borrowed
117.5


117.5


117.5

 
106.9


106.9


106.9

Investment securities, held-to-maturity
30.8


31.5


31.5

 
31.4


31.5


31.5

Loans, net of allowance for loan losses(a)
939.0


229.8

717.5

947.3

 
968.0


241.5

728.5

970.0

Other
56.5


55.7

0.9

56.6

 
60.5


59.6

1.0

60.6

Financial liabilities
 
 
 
 
 
 
 
 
 
 
 
Deposits
$
1,461.6

$

$
1,461.7

$

$
1,461.7

 
$
1,447.4

$

$
1,447.5

$

$
1,447.5

Federal funds purchased and securities loaned or sold under repurchase agreements
221.7


221.7


221.7

 
181.4


181.4


181.4

Short-term borrowings
64.1


64.1


64.1

 
62.1


62.1


62.1

Accounts payable and other liabilities
176.6

0.1

173.0

3.2

176.3

 
160.6

0.2

157.0

3.0

160.2

Beneficial interests issued by consolidated VIEs
25.9


25.9


25.9

 
20.2


20.2


20.2

Long-term debt and junior subordinated deferrable interest debentures
229.4


229.9

3.3

233.2

 
227.1


224.6

3.3

227.9

(a)
Fair value is typically estimated using a discounted cash flow model that incorporates the characteristics of the underlying loans (including principal, contractual interest rate and contractual fees) and other key inputs, including expected lifetime credit losses, interest rates, prepayment rates, and primary origination or secondary market spreads. For certain loans, the fair value is measured based on the value of the underlying collateral. The difference between the estimated fair value and carrying value of a financial asset or liability is the result of the different methodologies used to determine fair value as compared with carrying value. For example, credit losses are estimated for a financial asset’s remaining life in a fair value calculation but are estimated for a loss emergence period in the allowance for loan loss calculation; future loan income (interest and fees) is incorporated in a fair value calculation but is generally not considered in the allowance for loan losses.
The majority of the Firm’s lending-related commitments are not carried at fair value on a recurring basis on the Consolidated balance sheets. The carrying value of the wholesale allowance for lending-related commitments and the estimated fair value of these wholesale lending-related commitments were as follows for the periods indicated.
 
March 31, 2019
 
December 31, 2018
 
 
Estimated fair value hierarchy
 
 
 
Estimated fair value hierarchy
 
(in billions)
Carrying value(a)
Level 1
Level 2
Level 3
Total estimated fair value
 
Carrying value(a)
Level 1
Level 2
Level 3
Total estimated fair value(b)
Wholesale lending-related commitments
$
1.0

$

$

$
1.8

$
1.8

 
$
1.0

$

$

$
1.9

$
1.9

(a)
Excludes the current carrying values of the guarantee liability and the offsetting asset, each of which is recognized at fair value at the inception of the guarantees.
(b)
The prior period amounts have been revised to conform with the current period presentation.
The Firm does not estimate the fair value of consumer lending-related commitments. In many cases, the Firm can reduce or cancel these commitments by providing the borrower notice or, in some cases as permitted by law, without notice. For a further discussion of the valuation of lending-related commitments, refer to page 161 of JPMorgan Chase’s 2018 Form 10-K.